PRTN3 and vasculitis: The above was shown in a clinical study with 523 patients with vasculitis, where 81% of those with kidney-limited disease were positive for MPO-ANCA, while 94% of patients with bone destruction or saddle nose deformity were positive for PR3-ANCA [48].